Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Alonci

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|August 29, 2015
Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin ToxicityCaterina Musolino, Alessandro Allegra, Carmen Mannucci, et al.
European Journal of Haematology|March 20, 2013
Monoclonal antibodies: potential new therapeutic treatment against multiple myelomaAlessandro Allegra, Giuseppa Penna, Andrea Alonci, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|June 27, 2013
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximabAlessandro Allegra, Giacomo Oteri, Andrea Alonci, et al.
Acta Haematologica|October 10, 2009
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disordersCaterina Musolino, Alessandro Allegra, Giuseppa Penna, et al.
Oncology Letters|August 7, 2012
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndromeGiuseppa Penna, Alessandro Allegra, Andrea Alonci, et al.
Journal of Cellular Physiology|December 21, 2002
Differential levels of soluble endoglin (CD105) in myeloid malignanciesLuana Calabrò, Ester Fonsatti, Giacomo Bellomo, et al.
European Journal of Haematology|December 1, 2010
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitorsAlessandro Allegra, Emanuela Sant'antonio, Giuseppa Penna, et al.
Hematological Oncology|June 25, 2011
Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment optionsAlessandro Allegra, Andrea Alonci, Giuseppa Penna, et al.
European Journal of Haematology|May 13, 2014
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpuraSebastiano Gangemi, Alessandro Allegra, Paolo Sciarrone, et al.
Acta Haematologica|October 12, 2011
Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remissionAndrea Alonci, Alessandro Allegra, Sabina Russo, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|August 29, 2015
Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin ToxicityCaterina Musolino, Alessandro Allegra, Carmen Mannucci, et al.
European Journal of Haematology|March 20, 2013
Monoclonal antibodies: potential new therapeutic treatment against multiple myelomaAlessandro Allegra, Giuseppa Penna, Andrea Alonci, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|June 27, 2013
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximabAlessandro Allegra, Giacomo Oteri, Andrea Alonci, et al.
Acta Haematologica|October 10, 2009
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disordersCaterina Musolino, Alessandro Allegra, Giuseppa Penna, et al.
Oncology Letters|August 7, 2012
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndromeGiuseppa Penna, Alessandro Allegra, Andrea Alonci, et al.
Journal of Cellular Physiology|December 21, 2002
Differential levels of soluble endoglin (CD105) in myeloid malignanciesLuana Calabrò, Ester Fonsatti, Giacomo Bellomo, et al.
European Journal of Haematology|December 1, 2010
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitorsAlessandro Allegra, Emanuela Sant'antonio, Giuseppa Penna, et al.
Hematological Oncology|June 25, 2011
Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment optionsAlessandro Allegra, Andrea Alonci, Giuseppa Penna, et al.
European Journal of Haematology|May 13, 2014
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpuraSebastiano Gangemi, Alessandro Allegra, Paolo Sciarrone, et al.
Acta Haematologica|October 12, 2011
Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remissionAndrea Alonci, Alessandro Allegra, Sabina Russo, et al.
Pageof 4